Clinical trial
Femoral Nerve Block With Liposome Bupivacaine for Postsurgical Analgesia…
NCT01683071 · Pacira Pharmaceuticals, Inc, Industry · Completed
Key facts
| NCT number | NCT01683071 |
|---|---|
| Title | Femoral Nerve Block With Liposome Bupivacaine for Postsurgical Analgesia Following Total Knee Arthroplasty |
| Official title | A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Single Injection Femoral Nerve Block With Liposome Bupivacaine for Postsurgical Analgesia in Subjects Undergoing Total Knee Arthroplasty |
| Lead sponsor | Pacira Pharmaceuticals, Inc, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Postoperative Pain |
| Intervention type | Drug |
| Interventions | Placebo, EXPAREL 67 mg, EXPAREL 133 mg, EXPAREL 266 mg |
| Enrollment | 297 |
| Start date | Sep 1, 2012 |
| Primary completion | Dec 1, 2013 |
| Completion | Dec 1, 2013 |
| First posted | Sep 11, 2012 |
| Last update posted | Dec 9, 2020 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: